Ozempic (Glucagon-like peptide 1 receptor agonist) in social media posts: Unveiling user perspectives through Reddit topic modeling
Semaglutide, a Glucagon-like peptide 1 (GLP-1) receptor agonist marketed under the brand name Ozempic, is originally prescribed for diabetes treatment and obesity management. However, healthy individuals without a medical cause use Ozempic without medical supervision to improve their physical appear...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2024-12-01
|
| Серии: | Emerging Trends in Drugs, Addictions, and Health |
| Предметы: | |
| Online-ссылка: | http://www.sciencedirect.com/science/article/pii/S2667118224000163 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
